Spots Global Cancer Trial Database for braf v600 e mutation
Every month we try and update this database with for braf v600 e mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | NCT02721459 | Melanoma Skin Cancer | XL888 Vemurafenib Cobimetinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | NCT02721459 | Melanoma Skin Cancer | XL888 Vemurafenib Cobimetinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | NCT02721459 | Melanoma Skin Cancer | XL888 Vemurafenib Cobimetinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
